Results 71 to 80 of about 3,344 (173)

Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen–Thawed Embryo Transfer With Hormone Replacement Therapy

open access: yesReproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose To evaluate the combined effects of micronized vaginal progesterone (P4) dose and achieved serum P4 levels on reproductive outcomes in hormone replacement therapy–frozen embryo transfer (HRT‐FET) cycles by classifying patients according to both parameters.
Mami Sekiguchi   +8 more
wiley   +1 more source

Single-cell sequencing shows mosaic aneuploidy in most human embryos

open access: yesThe Journal of Clinical Investigation
Mammalian preimplantation embryos often contain chromosomal defects that arose in the first divisions after fertilization and affect a subpopulation of cells — an event known as mosaic aneuploidy. In this issue of the JCI, Chavli et al.
Sarah A. Robertson, Robert I. Richards
doaj   +1 more source

Preimplantation Genetic Screening in In Vitro Fertilization (IVF): A Comprehensive Review of Ethical, Clinical, and Technological Developments [PDF]

open access: yesJournal of Medical and Life Science
Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Screening (PGS) have become indispensable tools in In Vitro Fertilization (IVF) to increase pregnancy rates and enhance embryo choice.
Zina Al-Obaidi   +3 more
doaj   +1 more source

ChromInst: a multicentre evaluation of robustness in aneuploidy and structural rearrangement testing

open access: yesJournal of Translational Medicine
Background Preimplantation genetic testing for aneuploidy and for chromosomal structural rearrangement (PGT-A/-SR) can improve clinical pregnancy rates and live birth rates, and shorten the time to pregnancy.
Wenbin Niu   +21 more
doaj   +1 more source

Births from aneuploid embryos: where is the evidence?

open access: yesBMJ Connections. Clinical Genetics and Genomics
Background Preimplantation genetic testing for aneuploidy (PGT-A) is used principally to identify embryos with whole chromosome aneuploidy, which are generally considered non-viable. Reports of healthy live births following transfer of embryos classified
Manuel Viotti   +7 more
doaj   +1 more source

Poster Session 4

open access: yes
Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Preimplantation Genetic Testing for Aneuploidy Could Not Improve Cumulative Live Birth Rate Among 705 Couples with Unexplained Recurrent Implantation Failure

open access: yesThe Application of Clinical Genetics
Yang Liu,1– 6,* Xiangxin Lan,1– 6,* Juanjuan Lu,1– 6,* Qian Zhang,1– 6 Tingting Zhou,1– 6 Tianxiang Ni,1– 6 Junhao Yan1– 6 1Center for Reproductive Medicine, Shandong University, Jinan, Shandong, 250012, People’s Republic of China; 2Key ...
Liu Y   +6 more
doaj  

Investigating developmental characteristics of biopsied blastocysts stratified by mitochondrial copy numbers using time-lapse monitoring

open access: yesReproductive Biology and Endocrinology
Background For in vitro fertilization (IVF), mitochondrial DNA (mtDNA) levels in the trophectodermal (TE) cells of biopsied blastocysts have been suggested to be associated with the cells’ developmental potential. However, scholars have reached differing
Chun-I Lee   +11 more
doaj   +1 more source

Reply to Comment on “Clinical Significance of Biochemical Pregnancy Loss in Recurrent Pregnancy Loss Patients: Insights From Euploid Embryo Transfers Minimizing Embryonic Bias”

open access: yesReproductive Medicine and Biology
Background We appreciate the commentary by Satapathy, Mehta, and Sah on our study examining biochemical pregnancy loss (BPL) in recurrent pregnancy loss (RPL) following euploid embryo transfer.
Yoshimitsu Kuwabara
doaj   +1 more source

Preimplantation genetic diagnosis

open access: yesZdravniški Vestnik, 2013
Backg round: Preimplantation genetic diagnosis (PGD) is used to analyze embryos before their transfer into uterus. It is suitable for a group of patients who are at a substantial risk of conceiving a pregnancy affected by a known genetic defect.
Karin Writzl
doaj  

Home - About - Disclaimer - Privacy